The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes

URN to cite this document:: urn:nbn:de:bvb:355-epub-588856
DOI to cite this document:: 10.5283/epub.58885

Thomas, Maria

; Bayha, Christine ; Klein, Kathrin ; Müller, Simon ; Weiss, Thomas S.

; Schwab, Matthias ; Zanger, Ulrich M.

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 13 Aug 2024 13:16

Alternative links to fulltext:DOI DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Abstract

Background: The peroxisome proliferator-activated receptor alpha (PPAR alpha) controls lipid/energy homeostasis and inflammatory responses. The truncated splice variant PPAR alpha-tr was suggested to exert a dominant negative function despite being unable to bind consensus PPAR alpha DNA response elements. Methods: The distribution and variability factor of each PPAR alpha variant were assessed in the well-characterized cohort of human liver samples (N = 150) on the mRNA and protein levels. Specific siRNA-mediated downregulation of each transcript as well as specific overexpression with subsequent qRT-PCR analysis of downstream genes was used for investigation of specific functional roles of PPAR alpha-wt and PPAR alpha-tr forms in primary human hepatocytes. Results: Bioinformatic analyses of genome-wide liver expression profiling data suggested a possible role of PPAR alpha-tr in downregulating proliferative and pro-inflammatory genes. Specific gene silencing of both forms in primary human hepatocytes showed that induction of metabolic PPAR alpha-target genes by agonist WY14,643 was prevented by PPAR alpha-wt knock-down but neither prevented nor augmented by PPAR alpha-tr knock-down. WY14,643 treatment did not induce proliferative genes including MYC, CDK1, and PCNA, and knock-down of PPAR alpha-wt had no effect, while PPAR alpha-tr knock-down caused up to 3-fold induction of these genes. Similarly, induction of pro-inflammatory genes IL1B, PTGS2, and CCL2 by IL-6 was augmented by knock-down of PPAR alpha-tr but not of PPAR alpha-wt. In contrast to human proliferative genes, orthologous mouse genes were readily inducible by WY14,643 in PPAR alpha-tr non-expressing AML12 mouse hepatocytes. Induction was augmented by overexpression of PPAR alpha-wt and attenuated by overexpression of PPAR alpha-tr. Pro-inflammatory genes including IL-1 beta, CCL2 and TNF alpha were induced by WY14,643 in mouse and human cells and both PPAR alpha forms attenuated induction. As potential mechanism of PPAR alpha-tr inhibitory action we suggest crosstalk with WNT/beta-catenin pathway. Finally, treatment with WY14,643 in the presence of PPAR alpha-tr resulted in the significant reduction of cell viability of AML12 and human ovarian cancer cell line, SKOV3. Conclusions: Our data suggest that the truncated PPAR alpha splice variant functions as an endogenous inhibitor of proliferative and pro-inflammatory genes in human cells and that its absence in mouse may explain species-specific differences in fibrate-induced hepatocarcinogenesis.

Owner only: item control page

Download Statistics

Altmetric

Alternative Statistics (altmetrics)

More literature (via CORE)

Details

Preview

Indexed in

Export bibliographical data

Abstract

Abstract

Download Statistics

Downloads

Alternative Statistics (altmetrics)

More literature (via CORE)

University Library